Epstein-Barr Virus and Lymphomas: An Overview

[1]  E. Kieff.  Epstein-Barr virus and its replication , 1996 .

[2]  M. Ladanyi,et al.  Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. , 1994, The New England journal of medicine.

[3]  L. Young,et al.  Epstein-Barr virus persistence and virus-associated tumours , 1994, The Lancet.

[4]  U. Prasad,et al.  Analysis of epstein‐barr virus infection in nasopharyngeal biopsies from a group at high risk of nasopharyngeal carcinoma , 2009, International journal of cancer.

[5]  P. Heerde,et al.  Detection of Epstein–Barr virus nucleic acid sequences and protein in nodal T‐cell lymphomas: relation between latent membrane protein‐1 positivity and clinical course , 1993, Histopathology.

[6]  F. Khanim,et al.  HLA A2.1-restricted cytotoxic T cells recognizing a range of Epstein-Barr virus isolates through a defined epitope in latent membrane protein LMP2 , 1993, Journal of virology.

[7]  J. Delabie,et al.  The B7/BB1 antigen is expressed by Reed-Sternberg cells of Hodgkin's disease and contributes to the stimulating capacity of Hodgkin's disease-derived cell lines , 1993 .

[8]  Martine,et al.  Epstein-Barr virus-latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Correlation of lymphoma phenotype with three distinct patterns of viral latency. , 1993, The American journal of pathology.

[9]  H. Kawaguchi,et al.  Epstein-Barr virus-infected T lymphocytes in Epstein-Barr virus-associated hemophagocytic syndrome. , 1993, The Journal of clinical investigation.

[10]  R. Kraft,et al.  Association of the subtype 2 of the Epstein-Barr virus with T-cell non-Hodgkin's lymphoma of the midline granuloma type. , 1993, Blood.

[11]  J. Diebold,et al.  In situ demonstration of Epstein-Barr virus small RNAs (EBER 1) in acquired immunodeficiency syndrome-related lymphomas: correlation with tumor morphology and primary site. , 1993, Blood.

[12]  C. Meijer,et al.  Expression of Epstein-Barr virus latent gene products and related cellular activation and adhesion molecules in Hodgkin's disease and non-Hodgkin's lymphomas arising in patients without overt pre-existing immunodeficiency. , 1993, Human pathology.

[13]  M. Tiemann,et al.  Frequent latent Epstein-Barr virus infection of neoplastic T cells and bystander B cells in human immunodeficiency virus-negative European peripheral pleomorphic T-cell lymphomas. , 1993, Blood.

[14]  R. Warnke,et al.  Brief report: reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis. , 1993, The New England journal of medicine.

[15]  B. Nathwani,et al.  Epstein-Barr virus-associated non-Hodgkin's lymphoma in patients infected with the human immunodeficiency virus. , 1993, Blood.

[16]  K. Chang,et al.  High prevalence of Epstein-Barr virus in the Reed-Sternberg cells of HIV-associated Hodgkin's disease. , 1993, The American journal of pathology.

[17]  K. Chan,et al.  Epstein‐barr virus carriage by nasopharyngeal carcinoma in situ , 1993, International journal of cancer.

[18]  L. Young,et al.  Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells , 1993, The Journal of experimental medicine.

[19]  D. Cooper,et al.  Subtypes of Epstein-Barr virus (EBV) in Hodgkin's disease: association between B-type EBV and immunocompromise. , 1993, Blood.

[20]  B. Birmingham.  Epstein-Barr Virus and Hodgkin's Disease: Transcriptional Analysis of Virus Latency in the Malignant Cells By E. M. Deacon, G. Pallesen,* G. Niedobitek,~ J. Crocker, g L. Brooks, A. B. Rickinson, and L. S. Young , 1993 .

[21]  S. Hamilton-Dutoit,et al.  The association of Epstein-Barr virus (EBV) with T cell lymphoproliferations and Hodgkin's disease: two new developments in the EBV field. , 1993, Advances in cancer research.

[22]  H. Stein,et al.  Epstein-Barr virus and CD30+ malignant lymphomas. , 1993, Critical reviews in oncogenesis.

[23]  M. Tiemann,et al.  [Heterogeneous Epstein-Barr virus infection patterns in peripheral T cell lymphoma of the angioimmunoblastic lymphadenopathy type]. , 1992, Verhandlungen der Deutschen Gesellschaft fur Pathologie.

[24]  Young,et al.  Distribution and phenotype of Epstein-Barr virus-harboring cells in Hodgkin's disease. , 1992, Blood.

[25]  Levin Dc.  Monoclonal proliferation of T cells containing Epstein-Barr virus in fatal mononucleosis. , 1992 .

[26]  E. Kieff,et al.  Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies , 1992, The Journal of experimental medicine.

[27]  E. Kieff,et al.  Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development , 1992, The Journal of experimental medicine.

[28]  H. Stein,et al.  Patterns of Epstein-Barr virus infection in non-neoplastic lymphoid tissue. , 1992, Blood.

[29]  Q Y Yao,et al.  Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts , 1992, Journal of virology.

[30]  S. Swerdlow,et al.  Post‐transplant lymphoproliferative disorders: a morphologic, phenotypic and genotypic spectrum of disease , 1992, Histopathology.

[31]  D. Shibata,et al.  Epstein-Barr virus-associated gastric adenocarcinoma. , 1992, The American journal of pathology.

[32]  E. Jaffe,et al.  Detection and localization of Epstein-Barr viral genomes in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma. , 1992, Blood.

[33]  L. Young,et al.  Three transcriptionally distinct forms of Epstein-Barr virus latency in somatic cell hybrids: cell phenotype dependence of virus promoter usage. , 1992, Virology.

[34]  A. Rickinson,et al.  Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes , 1992, Journal of virology.

[35]  H. Stein,et al.  The Epstein-Barr virus encoded membrane protein (LMP) induces phenotypic changes in epithelial cells , 1992, Virchows Archiv. B, Cell pathology including molecular pathology.

[36]  A. Levine,et al.  The oncogenic potential of Epstein-Barr virus nuclear antigen 1 in transgenic mice. , 1992, Current topics in microbiology and immunology.

[37]  L. Young,et al.  Epstein-Barr virus infection in oral hairy leukoplakia: virus replication in the absence of a detectable latent phase. , 1991, The Journal of general virology.

[38]  H. Cubie,et al.  Epstein-Barr virus gene expression and epithelial cell differentiation in oral hairy leukoplakia. , 1991, The American journal of pathology.

[39]  D. Cooper,et al.  Subtypes of Epstein-Barr virus in human immunodeficiency virus-associated non-Hodgkin lymphoma. , 1991, Blood.

[40]  H. Stein,et al.  Epstein-Barr virus DNA and latent gene products in Ki-1 (CD30)-positive anaplastic large cell lymphomas. , 1991, Blood.

[41]  S. Hamilton-Dutoit,et al.  HIV-associated lymphoma: histopathology and association with Epstein-Barr virus genome related to clinical, immunological and prognostic features. , 1991, European journal of cancer.

[42]  H. Stein,et al.  Epstein–Barr virus and carcinomas: Undifferentiated carcinomas but not squamous cell carcinomas of the nasopharynx are regularly associated with the virus , 1991, The Journal of pathology.

[43]  E. Kieff,et al.  Restricted Epstein-Barr virus protein expression in Burkitt lymphoma is due to a different Epstein-Barr nuclear antigen 1 transcriptional initiation site. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[44]  L. Young,et al.  The Epstein-Barr virus carrier state: dominance of a single growth-transforming isolate in the blood and in the oropharynx of healthy virus carriers. , 1991, The Journal of general virology.

[45]  G. Packham,et al.  Differentiation-associated expression of the Epstein-Barr virus BZLF1 transactivator protein in oral hairy leukoplakia , 1991, Journal of virology.

[46]  S. Pileri,et al.  Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[47]  G. Klein,et al.  aberrant expression of HLA Class‐I antigens in burkitt lymphoma cells , 1991, International journal of cancer.

[48]  S. Hamilton-Dutoit,et al.  Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease , 1991, The Lancet.

[49]  T. Wu,et al.  Detection of ebv gene expression in reed‐sternberg cells of Hodgkin's disease , 1990, International journal of cancer.

[50]  E. Kieff,et al.  Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes , 1990, Journal of virology.

[51]  A. Inui,et al.  Detection of Epstein-Barr virus genome in benign polyclonal proliferative T cells of a young male patient , 1990 .

[52]  M. Rowe,et al.  Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line. , 1990, The Journal of general virology.

[53]  M. Yacoub,et al.  Immunohistology of Epstein-Barr virus-associated antigens in B cell disorders from immunocompromised individuals. , 1990, Transplantation.

[54]  E. Kieff,et al.  Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23 , 1990, Journal of virology.

[55]  E. Kieff,et al.  Human cytotoxic T-cell responses against Epstein-Barr virus nuclear antigens demonstrated by using recombinant vaccinia viruses. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[56]  T. Osato,et al.  Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma , 1990, The Lancet.

[57]  J. Locker,et al.  Molecular genetic analysis of lymphoid tumors arising after organ transplantation. , 1989, The American journal of pathology.

[58]  K. Yao,et al.  Two epithelial tumor cell lines (HNE-1 and HONE-1) latently infected with Epstein-Barr virus that were derived from nasopharyngeal carcinomas. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[59]  P. Farrell,et al.  The terminal protein gene 2 of Epstein-Barr virus is transcribed from a bidirectional latent promoter region. , 1989, The Journal of general virology.

[60]  E. Kieff,et al.  Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. , 1989, The New England journal of medicine.

[61]  L. Resnick,et al.  DETECTION OF A SECOND WIDESPREAD STRAIN OF EPSTEIN-BARR VIRUS , 1989, The Lancet.

[62]  H. Stein,et al.  Identification of Epstein-Barr virus-infected cells in tonsils of acute infectious mononucleosis by in situ hybridization. , 1989, Human pathology.

[63]  B. Griffith,et al.  The clinical spectrum, pathology, and clonal analysis of Epstein-Barr virus-associated lymphoproliferative disorders in heart-lung transplant recipients. , 1989, American journal of clinical pathology.

[64]  N. Harris,et al.  Hodgkin's disease and Epstein-Barr virus. Altered antibody pattern before diagnosis. , 1989, The New England journal of medicine.

[65]  E. Kieff,et al.  Distinction between Epstein-Barr virus type A (EBNA 2A) and type B (EBNA 2B) isolates extends to the EBNA 3 family of nuclear proteins , 1989, Journal of virology.

[66]  M. Rowe,et al.  The epstein‐barr virus: Host balance in acute infectious mononucleosis patients receiving acyclovir anti‐viral therapy , 1989, International journal of cancer.

[67]  M. Rowe,et al.  Epstein‐barr virus‐infected b cells persist in the circulation of acyclovir‐treated virus carriers , 1989, International journal of cancer.

[68]  I. Ernberg,et al.  Eradication of Epstein-Barr virus by allogeneic bone marrow transplantation: implications for sites of viral latency. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[69]  J. Sklar,et al.  Clonal analysis of transplant-associated lymphoproliferations based on the structure of the genomic termini of the Epstein-Barr virus , 1988 .

[70]  G. Klein,et al.  Differential expression of hla antigen of HLA anigens on human B‐cell lines of normal and malignant origin: A consequence of immune surveillance or a phenotypic vestige of the progenitor cells? , 1988, International journal of cancer.

[71]  G. Klein,et al.  Direct outgrowth of in vivo epstein‐barr virus (EBV)‐infected chronic lymphocytic leukemia (CLL) cells into permanent lines , 1988, International journal of cancer.

[72]  I. Kobayashi,et al.  Epstein-Barr virus genome-positive T lymphocytes in a boy with chronic active EBV infection associated with Kawasaki-like disease , 1988, Nature.

[73]  A. Rickinson,et al.  Downregulation of cell adhesion molecules LFA-3 and ICAM-1 in Epstein- Barr virus-positive Burkitt's lymphoma underlies tumor cell escape from virus-specific T cell surveillance , 1988, The Journal of experimental medicine.

[74]  M. Allday,et al.  ROLE OF EPITHELIUM IN EBV PERSISTENCE AND PATHOGENESIS OF B-CELL TUMOURS , 1988, The Lancet.

[75]  James F. Jones,et al.  T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections. , 1988, The New England journal of medicine.

[76]  C. Rooney,et al.  New type B isolates of Epstein-Barr virus from Burkitt's lymphoma and from normal individuals in endemic areas. , 1987, The Journal of general virology.

[77]  L. Young,et al.  Differences in B cell growth phenotype reflect novel patterns of Epstein‐Barr virus latent gene expression in Burkitt's lymphoma cells. , 1987, The EMBO journal.

[78]  E. Kieff,et al.  Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[79]  L. Young,et al.  Influence of the Epstein-Barr virus nuclear antigen EBNA 2 on the growth phenotype of virus-transformed B cells , 1987, Journal of virology.

[80]  N. Raab-Traub,et al.  The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation , 1986, Cell.

[81]  G. Lenoir,et al.  Geographical prevalence of two types of Epstein-Barr virus. , 1986, Virology.

[82]  E. Lennette,et al.  Replication of Epstein-Barr virus within the epithelial cells of oral "hairy" leukoplakia, an AIDS-associated lesion. , 1985, The New England journal of medicine.

[83]  E. Kieff,et al.  An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells , 1985, Cell.

[84]  M. Epstein,et al.  Distinctions between endemic and sporadic forms of epstein‐barr virus‐positive burkitt's lymphoma , 1985, International journal of cancer.

[85]  M. Epstein,et al.  A re‐examination of the epstein‐barr virus carrier state in healthy seropositive individuals , 1985, International journal of cancer.

[86]  E. Kieff,et al.  U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[87]  M. Epstein,et al.  T-cell-mediated regression of "spontaneous" and of Epstein-Barr virus-induced B-cell transformation in vitro: studies with cyclosporin A. , 1984, Cellular immunology.

[88]  N. Raab-Traub,et al.  Epstein-Barr virus replication in oropharyngeal epithelial cells. , 1984, The New England journal of medicine.

[89]  L. Heston,et al.  Non-immortalizing P3J-HR-1 Epstein-Barr virus: a deletion mutant of its transforming parent, Jijoye , 1982, Journal of virology.

[90]  G. Bornkamm,et al.  Deletion of the Nontransforming Epstein-Barr Virus Strain P3HR-1 Causes Fusion of the Large Internal Repeat to the DSL Region , 1982, Journal of virology.

[91]  G. de‐Thé,et al.  Infectious mononucleosis and Hodgkin's disease , 1978, International journal of cancer.

[92]  G. Miller,et al.  Oropharyngeal excretion of Epstein-Barr virus by renal transplant recipients and other patients treated with immunosuppressive drugs. , 1974, Lancet.

[93]  E. Perlin,et al.  Oral excretion of Epstein-Barr virus by healthy subjects and patients with infectious mononucleosis. , 1972, Lancet.

[94]  G. Klein,et al.  The establishment of lymphoblastoid lines from adult and fetal human lymphoid tissue and its dependence on EBV , 1971, International journal of cancer.